Dutta, P., Kumar, Y., Babu, A
Used for: GH-releasing peptides (CJC-1295 + Ipamorelin) MOTS-C AOD-9604 GLP-1based peptides BPC-157 (systemic use) Technique: Use a 2931 gauge insulin syringe Pinch a fold of skin Insert needle at 4590 degrees Inject slowly into the subcutaneous layer Rotate sites to avoid irritation Intradermal / Mesotherapy-Style Injections Ready to put this into practice
[92] that describes a novel pathway of macrophage endocytosis of fibrin
Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA
Re-run the calculation whenever vial size, water amount, syringe type, or target dose changes
121 Additionally, GLP-1 induces conditioned taste aversion suggesting that the peptide may suppress feeding by inducing a sensation of sickness